Your browser doesn't support javascript.
loading
A Wirelessly Controlled Scalable 3D-Printed Microsystem for Drug Delivery.
Forouzandeh, Farzad; Ahamed, Nuzhet N; Zhu, Xiaoxia; Bazard, Parveen; Goyal, Krittika; Walton, Joseph P; Frisina, Robert D; Borkholder, David A.
Afiliación
  • Forouzandeh F; Department of Microsystems Engineering, Rochester Institute of Technology, Rochester, NY 14623, USA.
  • Ahamed NN; Department of Microsystems Engineering, Rochester Institute of Technology, Rochester, NY 14623, USA.
  • Zhu X; Department of Medical Engineering, Global Center for Hearing & Speech Research, University of South Florida, Tampa, FL 33620, USA.
  • Bazard P; Department of Medical Engineering, Global Center for Hearing & Speech Research, University of South Florida, Tampa, FL 33620, USA.
  • Goyal K; Department of Microsystems Engineering, Rochester Institute of Technology, Rochester, NY 14623, USA.
  • Walton JP; Department of Medical Engineering, Global Center for Hearing & Speech Research, University of South Florida, Tampa, FL 33620, USA.
  • Frisina RD; Department of Chemical, Biological & Materials Engineering, University of South Florida, Tampa, FL 33620, USA.
  • Borkholder DA; Department of Communication Sciences & Disorders, Global Center for Hearing & Speech Research, University of South Florida, Tampa, FL 33620, USA.
Pharmaceuticals (Basel) ; 14(6)2021 Jun 04.
Article en En | MEDLINE | ID: mdl-34199855
ABSTRACT
Here we present a 3D-printed, wirelessly controlled microsystem for drug delivery, comprising a refillable microreservoir and a phase-change peristaltic micropump. The micropump structure was inkjet-printed on the back of a printed circuit board around a catheter microtubing. The enclosure of the microsystem was fabricated using stereolithography 3D printing, with an embedded microreservoir structure and integrated micropump. In one configuration, the microsystem was optimized for murine inner ear drug delivery with an overall size of 19 × 13 × 3 mm3. Benchtop results confirmed the performance of the device for reliable drug delivery. The suitability of the device for long-term subcutaneous implantation was confirmed with favorable results of implantation of a microsystem in a mouse for six months. The drug delivery was evaluated in vivo by implanting four different microsystems in four mice, while the outlet microtubing was implanted into the round window membrane niche for infusion of a known ototoxic compound (sodium salicylate) at 50 nL/min for 20 min. Real-time shifts in distortion product otoacoustic emission thresholds and amplitudes were measured during the infusion, demonstrating similar results with syringe pump infusion. Although demonstrated for one application, this low-cost design and fabrication methodology is scalable for use in larger animals and humans for different clinical applications/delivery sites.
Palabras clave

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: Pharmaceuticals (Basel) Año: 2021 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: Pharmaceuticals (Basel) Año: 2021 Tipo del documento: Article